| Deborah Smith, LMFT | |
|
309 Court Ave Ste 241, Des Moines, IA 50309-2282 | |
| (515) 244-2267 | |
| Not Available |
| Full Name | Deborah Smith |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 309 Court Ave Ste 241, Des Moines, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073099081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 087144 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Smith, LMFT 309 Court Ave Ste 241, Des Moines, IA 50309-2282 Ph: () - | Deborah Smith, LMFT 309 Court Ave Ste 241, Des Moines, IA 50309-2282 Ph: (515) 244-2267 |
News Archive
The value of intersecting the sequencing of individuals' exomes or full genomes to find rare genetic variants - on a large scale - with their detailed electronic health record information has "myriad benefits, including the illumination of basic human biology, the early identification of preventable and treatable illnesses, and the identification and validation of new therapeutic targets," wrote Daniel J. Rader, MD, chair of the Department of Genetics, in the Perelman School of Medicine at the University of Pennsylvania, in Science this week, with Scott M. Damrauer, MD, an assistant professor of Surgery at Penn and the Veterans Affairs Medical Center in Philadelphia.
A new target for control of early-stage asthma has been identified by McGill University professor Qutayba Hamid working as part of a team whose landmark study appears in the latest issue of the journal Science
Aphios Corporation today announced that it has been awarded a RC-1 Challenge grant (No. 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health's (NIH) American Recovery and Reinvestment Act (ARRA) funds to develop a generally-applicable pathogen inactivation technology for blood products.
CRISPR is one of the most exciting advances in gene-based medicine in decades. A uniquely powerful tool for editing the genome, it allows scientists to manipulate DNA with unprecedented precision by deleting unwanted or faulty genes and replacing them with different ones. Its promise in this field of medicine is immense, unlocking the potential for novel treatments across a wide range of therapeutic areas.
› Verified 3 days ago
Mrs. Avery Harshman, TLMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 950 15th St, Des Moines, IA 50314 Phone: 515-242-8406 | |
Mrs. Kristin Hepworth, MFT, CADC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 700 E University Ave, Des Moines, IA 50316 Phone: 515-263-4007 Fax: 515-263-2463 | |
Amber Roberts, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 309 Court Ave Ste 241, Des Moines, IA 50309 Phone: 515-901-2974 Fax: 515-875-4817 | |
Carrie Crotts, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4908 Franklin Ave, Des Moines, IA 50310 Phone: 515-280-4930 Fax: 515-309-0686 | |
Ms. Kimberly Sue Brangoccio, LMFT, CEAP, IAADC Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 700 E University Ave, Ilh 4-mid, Des Moines, IA 50316 Phone: 515-263-2442 Fax: 515-263-2463 | |
Renata Olsen, Couples Therapy Medicare: Medicare Enrolled Practice Location: 309 Court Ave Ste 241, Des Moines, IA 50309 Phone: 515-901-2974 Fax: 515-875-4817 |